Literature DB >> 201259

Assessment of inherent fluctuations of mitotic and labelling indices of human tumours.

W A Aherne, R S Camplejohn, M Al-Wiswasy, D Ford, A M Kellerer.   

Abstract

A method is presented to evaluate the influence of statistical errors and inherent variation on the determination of mitotic and labelling indices of human tumours. In most of the experiments reported here, sufficient cells were counted to yield a statistical error which is small in comparison to the inherent differences in the proliferative indices, both between different sites in the same tumour and between different tumours of the same histological type. These inherent fluctuations are, theefore, a critical factor in cell kinetic studies of human tumours.

Entities:  

Mesh:

Year:  1977        PMID: 201259      PMCID: PMC2025402          DOI: 10.1038/bjc.1977.234

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  4 in total

1.  Cellular proliferation patterns in an experimental rhabdomyosarcoma in the rat.

Authors:  A F Hermens; G W Barendsen
Journal:  Eur J Cancer       Date:  1967-11       Impact factor: 9.162

2.  Cell proliferation in human melanoma.

Authors:  S Shirakawa; J K Luce; I Tannock; E Frei
Journal:  J Clin Invest       Date:  1970-06       Impact factor: 14.808

3.  In vitro labelling of childhood cancers with tritiated thymidine.

Authors:  R S Camplejohn; W A Aherne
Journal:  Br J Cancer       Date:  1974-06       Impact factor: 7.640

4.  The relation between cell proliferation and the vascular system in a transplanted mouse mammary tumour.

Authors:  I F Tannock
Journal:  Br J Cancer       Date:  1968-06       Impact factor: 7.640

  4 in total
  2 in total

1.  Proliferation Markers and Their Uses in the Study of Endocrine Tumors.

Authors:  Giuseppe Pelosi; Giuseppe Zamboni
Journal:  Endocr Pathol       Date:  1996       Impact factor: 3.943

2.  Cell proliferation of colonic neoplasms in dimethylhydrazine-treated rats.

Authors:  J P Sunter; D L Hull; D R Appleton; A J Watson
Journal:  Br J Cancer       Date:  1980-07       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.